Pharmacokinetics and Safety of Once-Daily Intravenous Busulfan with Bortezomib in Patients with Relapsed Multiple Myeloma Undergoing a Second Autologous Hematopoietic Stem Cell Transplantation

Autor: Freytes, C.O., Toro, J.J., Yeh, R.F., Stadtmauer, E.A., Ratanatharathorn, V., Akpek, G., Sahovic, E., Tricot, G.J., Shaughnessy, P.J., White, D.J., Rodriguez, T.E., Solomon, S.R., Yu, L., Patil, S., Sun, Y., Armstrong, E., Elekes, A., Kato, K., Reece, D.E.
Zdroj: In Biology of Blood and Marrow Transplantation 2012 18(2) Supplement:S253-S253
Databáze: ScienceDirect